| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/23/2005 | US6933364 Secretory thyroid stimulating hormone receptor, and method for assaying anti-thyroid stimulating hormone receptor antibody using the same |
| 08/23/2005 | US6933331 Nanotechnology for drug delivery, contrast agents and biomedical implants |
| 08/23/2005 | US6933284 Incubating a mixture so a complex forms between low density lipoprotein and proteoglycan with a candidate compound and determining the difference in the amount of complex present in the presence and absence of the compound |
| 08/23/2005 | US6933153 Metal ion specific capacity affinity sensor |
| 08/23/2005 | US6933152 Artificial human feces |
| 08/23/2005 | US6933150 Genetic transduction of cells with nucleic acid codes for transmembrane efflux pumps, gene expression and culturing, for use in bone marrow grafting and gene therapy |
| 08/23/2005 | US6933147 Human cyclic nucleotide-gated channel polypeptide |
| 08/23/2005 | US6933143 Automated enzyme-linked immunosorbent assay device with ONP-GP |
| 08/23/2005 | US6933135 monoclonal antibody having intracellular domain of leukocyte antigen related molecule and domain of CD45; for prophylaxis and diagnosis of syndrome X, arteriosclerosis, and cardiovascular disorders based on insulin resistance |
| 08/23/2005 | US6933129 Method for culturing and assaying cells |
| 08/23/2005 | US6933128 Cell-based assay for screening cox-2 inhibitors |
| 08/23/2005 | US6933127 Substrate for PP2C |
| 08/23/2005 | US6933126 Enzyme activation; detection, measurement |
| 08/23/2005 | US6933125 Human c-Maf compositions and methods of use thereof |
| 08/23/2005 | US6933124 Human GABAB receptor 1 promoters |
| 08/23/2005 | US6933123 Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
| 08/23/2005 | US6933122 for defining predisposition to development of neoplastic disease; for maintaining synaptic connections between neurons and targets; drug screening |
| 08/23/2005 | US6933119 Methods and compositions for the detection and treatment of multiple sclerosis |
| 08/23/2005 | US6933117 Composition for use in the automated medical and genetic analysis |
| 08/23/2005 | US6933116 Nucleic acid ligand binding site identification |
| 08/23/2005 | US6933112 attachment layer comprises diamond-like carbon |
| 08/23/2005 | US6933109 Screening fluid sample for preferential particles; obtain fluid sample, insert into sedimentation container, centrifuge, detect particles bound to solid phase |
| 08/23/2005 | US6933108 Treating viral disease in mammals; administer viricide to mammal, monitor activity of virus, reduced viral activity indicates effective viricide |
| 08/23/2005 | US6933107 For inhibition of cholesterol absorption |
| 08/23/2005 | US6933106 Platelet immunoglobulin bead suspension and flow cytometry |
| 08/23/2005 | US6933104 administration of catalytic iron chelator compound, then urine screening for creatinine levels |
| 08/23/2005 | US6932969 Ig fractions having immunomodulatory activity |
| 08/23/2005 | US6932941 Method and apparatus for improved gas detection |
| 08/23/2005 | US6932894 Biosensor membranes composed of polymers containing heterocyclic nitrogens |
| 08/23/2005 | US6932893 System for electrophysiological measurements |
| 08/23/2005 | US6932845 Using drops; storage; crystallization; detection of images |
| 08/23/2005 | US6931949 Apparatus for measuring the weight of small items |
| 08/23/2005 | US6931926 Liquid depth sensing system with liquid identification capability |
| 08/23/2005 | US6931913 Chemical agent detector |
| 08/23/2005 | CA2476033A1 Method for screening a substance which can suppress degradation of a nuclear receptor or a substance which can promote degradation of a nuclear receptor |
| 08/23/2005 | CA2153235C Compounds having selectivity for retinoid x receptors |
| 08/23/2005 | CA2142300C Methods for detecting alzheimer's disease |
| 08/23/2005 | CA2131919C Improved log scanning |
| 08/23/2005 | CA2094276C Antibodies against the urokinase receptor and their use |
| 08/19/2005 | CA2507428A1 Hydrogen gas sensor |
| 08/18/2005 | WO2005076015A1 Taurine transporter tau1 expressed in blood brain barrier cells |
| 08/18/2005 | WO2005076014A1 Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 2 (mglur2) |
| 08/18/2005 | WO2005076013A2 Process for screening glycoform-specific antibodies |
| 08/18/2005 | WO2005076012A2 Novel splice variants and methods of use thereof |
| 08/18/2005 | WO2005076011A2 Use of glut1 transporter expressed in blood brain barrier cells for screening for pharmacologically active substances |
| 08/18/2005 | WO2005076010A2 Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential |
| 08/18/2005 | WO2005076009A2 Method for identifying and quantifying of tumour-associated peptides |
| 08/18/2005 | WO2005076008A1 Diagnostics and therapeutics for diseases associated with phosphate regulating endopeptidase homolog (phex) |
| 08/18/2005 | WO2005076007A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y12 (p2y12) |
| 08/18/2005 | WO2005076006A1 Diagnosis of sepsis by the selective determination of the concentration of cu/zn superoxide dismutase (cu/zn sod) in patient samples |
| 08/18/2005 | WO2005076005A2 A method for classifying a tumor cell sample based upon differential expression of at least two genes |
| 08/18/2005 | WO2005076004A1 Diagnostics and therapeutics for diseases associated with human nuclear receptor nr1d1 (nr1d1) |
| 08/18/2005 | WO2005076003A2 Diagnostics and therapeutics for diseases associated with plasma glutamate carboxypeptidase (pgcp) |
| 08/18/2005 | WO2005076002A1 Antibody assay method |
| 08/18/2005 | WO2005076001A2 A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual |
| 08/18/2005 | WO2005076000A1 Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies |
| 08/18/2005 | WO2005075999A1 Information-encoded tests and method |
| 08/18/2005 | WO2005075998A1 Improved lateral flow binding assay |
| 08/18/2005 | WO2005075997A1 Method of detecting analyte with use of magnetic bead |
| 08/18/2005 | WO2005075996A1 Baseboard for constructing surface plasmon resonane antibody array sensor and method of constructing the same |
| 08/18/2005 | WO2005075995A1 Sensor |
| 08/18/2005 | WO2005075994A2 Biosensor and method for operating the latter |
| 08/18/2005 | WO2005075993A1 Selective labeling agent for phosphoproteome analysis and phosphorylated site analysis |
| 08/18/2005 | WO2005075992A1 Mct1 transporter expressed in blood brain barrier cells |
| 08/18/2005 | WO2005075991A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor sreb3 (sreb3) |
| 08/18/2005 | WO2005075990A2 Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a2 (nr4a2) |
| 08/18/2005 | WO2005075989A1 Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 5 (mglur5) |
| 08/18/2005 | WO2005075988A1 Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 7 (mglur7) |
| 08/18/2005 | WO2005075987A2 Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 1 (mglur1) |
| 08/18/2005 | WO2005075986A2 Method and kit for the measurement of neutrophil cell activation |
| 08/18/2005 | WO2005075985A1 Throughflow device for measuring platelet function of primary hemostasis, aggregation and/or coagulation and/or viscosity of blood |
| 08/18/2005 | WO2005075984A1 Vessel for collecting excrement |
| 08/18/2005 | WO2005075983A2 Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a3 (nr4a3) |
| 08/18/2005 | WO2005075982A2 Method for the rapid diagnosis of targets in human body fluids |
| 08/18/2005 | WO2005075981A1 Method for determining microbiological pollution of aquatic media and device for carrying out said method |
| 08/18/2005 | WO2005075980A1 Method and system for determining the parameters of a process medium |
| 08/18/2005 | WO2005075977A1 Method for measurement of immature granulocytes |
| 08/18/2005 | WO2005075973A2 Acousto-mechanical detection systems and methods of use |
| 08/18/2005 | WO2005075972A1 Fingerprinting of complex hydrocarbon containing mixtures |
| 08/18/2005 | WO2005075969A1 Sensor and method for the production thereof |
| 08/18/2005 | WO2005075966A1 Apparatus for measuring work functions of materials |
| 08/18/2005 | WO2005075956A1 Tribometer |
| 08/18/2005 | WO2005075955A1 Glazing with sound insulating property |
| 08/18/2005 | WO2005075954A1 Benzene sensor and method for manufacturing same |
| 08/18/2005 | WO2005075684A2 Use of organic anion transporter b in screens for candidate substrates for crossing the blood brain barrier |
| 08/18/2005 | WO2005075681A1 Method of examining sensitivity of cancer cell to anticancer agent |
| 08/18/2005 | WO2005075680A1 Method of detecting nucleic acid and utilization thereof |
| 08/18/2005 | WO2005075674A1 Diagnostic and therapeutic use of kcne4 gene and protein for alzheimer disease |
| 08/18/2005 | WO2005075669A1 Reverse transcription based method for detecting gene expression in a cell |
| 08/18/2005 | WO2005075666A2 Diagnostics and therapeutics for diseases associated with puromycin sensitive aminopeptidase npepps (npepps) |
| 08/18/2005 | WO2005075665A2 Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1) |
| 08/18/2005 | WO2005075662A2 Diagnostics and therapeutics for diseases associated with kallikrein 2 (klk2) |
| 08/18/2005 | WO2005075647A1 Humanized antibody |
| 08/18/2005 | WO2005075641A1 Screening method |
| 08/18/2005 | WO2005075638A1 Gene detection field-effect device and method of analyzing gene polymorphism therewith |
| 08/18/2005 | WO2005075629A1 A method and apparatus for orienting spherical cells |
| 08/18/2005 | WO2005075513A1 Dj-1 derivative having acidified cysteine residue |
| 08/18/2005 | WO2005075512A1 Crystal structures and models for fc receptors and uses thereof in the design or identification of fc receptor modulator compounds |
| 08/18/2005 | WO2005075499A1 Method for treating a polymer material, method for controlling a fermentation catalysis and a chemical analysis device |
| 08/18/2005 | WO2005075493A1 Glycolipid-containing compound, biosensor having the same fixed thereto, fine particle containing glycolipid, detection reagent containing the fine particle, and method of detecting compound combining with sugar |